최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Clinics in liver disease, v.4 no.4, 2000년, pp.805 - 814
Holme, Elisabeth , Lindstedt, Sven
NTBC treatment has greatly improved the survival of patients with acute tyrosinemia and has reduced the need for liver transplantation during early childhood. In patients in whom treatment with NTBC was started early in life, 2 cases (1%) of HCC have occurred during the first year of treatment, but ...
Buist 203 1985 Inherited Diseases of Amino-acid Metabolism Tyrosinaemia type II
J Inherit Metab Dis Dionisi-Vici 20 suppl 1 15 1997 Tyrosinemia type I with early metastatic hepatocellular carcinoma: Combined treatment with NTBC, chemotherapy and surgical mass removal
Toxicol Appl Pharmacol Ellis 133 12 1995 10.1006/taap.1995.1121 Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione
J Pediatr Gastroenterol Nutr Freese 13 10 1991 10.1097/00005176-199107000-00002 Early liver transplantation is indicated for tyrosinemia type I
J Neurol Neurosurg Psychiatry Gibbs 56 1129 1993 10.1136/jnnp.56.10.1129 Peripheral neuropathy as the presenting feature of tyrosinemia type I and effectively treated with an inhibitor of 4-hydroxyphenylpyruvate dioxygenase
Clin Chim Acta Grenier 123 93 1992 10.1016/0009-8981(82)90117-6 Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia
International Pediatrics Holme 10 41 1995 Treatment of tyrosinemia type I with an enzyme inhibitor
Curr Opin Pediatr Holme 7 726 1995 Diagnosis and management of tyrosinemia type I
J Inherit Metab Dis Holme 21 507 1998 10.1023/A:1005410820201 Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione)
Eur J Pediatr Hudak 153 187 1994 10.1007/s004310050119 Evaluation of delta-aminolaevulinic acid excretion in random urine samples of children
Morphometry and electron microscopy J Inherit Metab Dis Kerckaert 20 suppl 1 13 1997 Secondary alterations of hepatic peroxisomes in tyrosinaemia type I
Proc Natl Acad Sci U S A Lindblad 74 4641 1977 10.1073/pnas.74.10.4641 On the enzymic defects in hereditary tyrosinemia
Lancet Lindstedt 340 813 1992 10.1016/0140-6736(92)92685-9 Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase
J Inherit Metab Dis Lock 21 498 1998 10.1023/A:1005458703363 From toxicological problem to therapeutic use: The discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug
Transplantation Luks 56 1376 1993 10.1097/00007890-199312000-00019 Surgical and metabolic aspects of liver transplantation for tyrosinemia
New Engl J Med Mitchell 322 432 1990 10.1056/NEJM199002153220704 Neurologic crises in hereditary tyrosinemia
Eur J Pediatr Mohan 158 suppl 2 S49 1999 10.1007/PL00014321 Indications and outcome of liver transplantation in tyrosinaemia type 1
J Inherit Metab Dis Perez-Cerda 18 119 1995 10.1007/BF00711744 Liver transplantation in nine Spanish patients with tyrosinaemia type I
J Inher Metab Dis Pronicka 19 234 1996 10.1007/BF01799438 Treatment of two children with hereditary tyrosinaemia type I and long-standing renal disease with a 4-hydroxyphenylpyruvate dioxygenase (NTBC)
Hepatology van Spronsen 20 1187 1994 10.1002/hep.1840200513 Hereditary tyrosinemia type I: A new clinical classification with difference in prognosis on dietary treatment
J Inherit Metab Dis Ros 22 665 1999 10.1023/A:1005594416973 NTBC as palliative treatment in chronic tyrosinaemia type I
J Pediatr Weinberg 88 434 1976 10.1016/S0022-3476(76)80259-4 Occurrence of hepatoma in chronic form of hereditary tyrosinemia
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.